A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis [clinicaltrials:NCT00499551]
A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis [clinicaltrials:NCT00499551]
Bio2RDF identifier
NCT00499551
Bio2RDF namespace
clinicaltrials
Bio2RDF uri
http://bio2rdf.org/clinicaltrials:NCT00499551
identifiers.org URI
anticipated enrollment [clinicaltrials_vocabulary:anticipated-enrollment]
authority [clinicaltrials_vocabulary:authority]
brief summary [clinicaltrials_vocabulary:brief-summary]
The multiple properties ...... sing a new generation device.
brief title [clinicaltrials_vocabulary:brief-title]
A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
completion date [clinicaltrials_vocabulary:completion-date]
2009-09-01T00:00:00Z
condition [clinicaltrials_vocabulary:condition]
condition browse [clinicaltrials_vocabulary:condition-browse]
condition mesh [clinicaltrials_vocabulary:condition-mesh]
country [clinicaltrials_vocabulary:country]
detailed description [clinicaltrials_vocabulary:detailed-description]
The multiple properties ...... 30 days after the treatment.
download date [clinicaltrials_vocabulary:download-date]
ClinicalTrials.gov processed this data on August 10, 2015
eligibility [clinicaltrials_vocabulary:eligibility]
firstreceived date [clinicaltrials_vocabulary:firstreceived-date]
2007-07-09T00:00:00Z
has expanded access [clinicaltrials_vocabulary:has-expanded-access]
intervention [clinicaltrials_vocabulary:intervention]
keyword [clinicaltrials_vocabulary:keyword]
Anterior Uveitis
Dexamethasone
Intermediate Uveitis
Iontophoresis
Panuveitis
Posterior Uveitis
lastchanged date [clinicaltrials_vocabulary:lastchanged-date]
2008-07-08T00:00:00Z
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
location [clinicaltrials_vocabulary:location]
nct id [clinicaltrials_vocabulary:nct-id]
NCT00499551
number of arms [clinicaltrials_vocabulary:number-of-arms]
official title [clinicaltrials_vocabulary:official-title]
A Phase I/IIa Study of the Tre ...... ered by a Iontophoresis Device
org study id [clinicaltrials_vocabulary:org-study-id]
Iontophoresis001
overall official [clinicaltrials_vocabulary:overall-official]
overall status [clinicaltrials_vocabulary:overall-status]
oversight [clinicaltrials_vocabulary:oversight]
phase [clinicaltrials_vocabulary:phase]
reference [clinicaltrials_vocabulary:reference]
source [clinicaltrials_vocabulary:source]
start date [clinicaltrials_vocabulary:start-date]
2007-09-01T00:00:00Z
study design [clinicaltrials_vocabulary:study-design]
study type [clinicaltrials_vocabulary:study-type]
url [clinicaltrials_vocabulary:url]
verification date [clinicaltrials_vocabulary:verification-date]
2008-07-01T00:00:00Z
why stopped [clinicaltrials_vocabulary:why-stopped]
The drug needed for the study is not available in Mexico anymore.
identifier
clinicaltrials:NCT00499551
title
A Phase I/IIa Study for the Treatment of Uveitis With Iontophoresis
@en
type
label
A Phase I/IIa Study for the Tr ...... s [clinicaltrials:NCT00499551]
@en